Dome JS - Search Results

1

Telomerase expression predicts unfavorable outcome in osteosarcoma.

Sanders RP, Drissi R, Billups CA, Daw NC, Valentine MB, Dome JS. Sanders RP, et al. Among authors: dome js. J Clin Oncol. 2004 Sep 15;22(18):3790-7. doi: 10.1200/JCO.2004.03.043. J Clin Oncol. 2004. PMID: 15365076

2

Telomerase activity and prognosis in primary breast cancers.

Carey LA, Kim NW, Goodman S, Marks J, Henderson G, Umbricht CB, Dome JS, Dooley W, Amshey SR, Sukumar S. Carey LA, et al. Among authors: dome js. J Clin Oncol. 1999 Oct;17(10):3075-81. doi: 10.1200/JCO.1999.17.10.3075. J Clin Oncol. 1999. PMID: 10506602

3

Treatment of refractory osteosarcoma with fractionated cyclophosphamide and etoposide.

Rodríguez-Galindo C, Daw NC, Kaste SC, Meyer WH, Dome JS, Pappo AS, Rao BN, Pratt CB. Rodríguez-Galindo C, et al. Among authors: dome js. J Pediatr Hematol Oncol. 2002 May;24(4):250-5. doi: 10.1097/00043426-200205000-00006. J Pediatr Hematol Oncol. 2002. PMID: 11972091

4

Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children's Research Hospital.

Dome JS, Liu T, Krasin M, Lott L, Shearer P, Daw NC, Billups CA, Wilimas JA. Dome JS, et al. J Pediatr Hematol Oncol. 2002 Mar-Apr;24(3):192-8. doi: 10.1097/00043426-200203000-00007. J Pediatr Hematol Oncol. 2002. PMID: 11990305 Clinical Trial.

5

Clinical and biologic significance of nuclear unrest in Wilms tumor.

Hill DA, Shear TD, Liu T, Billups CA, Singh PK, Dome JS. Hill DA, et al. Among authors: dome js. Cancer. 2003 May 1;97(9):2318-26. doi: 10.1002/cncr.11325. Cancer. 2003. PMID: 12712489 Free article.

6

Giant cell tumor of bone with pulmonary metastases.

Okamoto Y, Mathew S, Daw NC, Neel MD, McCarville MB, Dome JS, Hill DA. Okamoto Y, et al. Among authors: dome js. Med Pediatr Oncol. 2003 Nov;41(5):454-9. doi: 10.1002/mpo.10258. Med Pediatr Oncol. 2003. PMID: 14515387 No abstract available.

7

Disappearance of the telomere dysfunction-induced stress response in fully senescent cells.

Bakkenist CJ, Drissi R, Wu J, Kastan MB, Dome JS. Bakkenist CJ, et al. Among authors: dome js. Cancer Res. 2004 Jun 1;64(11):3748-52. doi: 10.1158/0008-5472.CAN-04-0453. Cancer Res. 2004. PMID: 15172978

8

Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma.

Geller JI, Dome JS. Geller JI, et al. Among authors: dome js. Cancer. 2004 Oct 1;101(7):1575-83. doi: 10.1002/cncr.20548. Cancer. 2004. PMID: 15378495 Free article. Review.

9

High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor.

Dome JS, Bockhold CA, Li SM, Baker SD, Green DM, Perlman EJ, Hill DA, Breslow NE. Dome JS, et al. J Clin Oncol. 2005 Dec 20;23(36):9138-45. doi: 10.1200/JCO.2005.00.562. Epub 2005 Sep 19. J Clin Oncol. 2005. PMID: 16172460

10

Cefixime allows greater dose escalation of oral irinotecan: a phase I study in pediatric patients with refractory solid tumors.

Furman WL, Crews KR, Billups C, Wu J, Gajjar AJ, Daw NC, Patrick CC, Rodriguez-Galindo C, Stewart CF, Dome JS, Panetta JC, Houghton PJ, Santana VM. Furman WL, et al. Among authors: dome js. J Clin Oncol. 2006 Feb 1;24(4):563-70. doi: 10.1200/JCO.2005.03.2847. J Clin Oncol. 2006. PMID: 16446328 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters